Eli Lilly and Company
PulseAugur coverage of Eli Lilly and Company — every cluster mentioning Eli Lilly and Company across labs, papers, and developer communities, ranked by signal.
5 天有情绪数据
-
人工智能在医疗保健领域的应用：专家就信任、数据和集成挑战展开辩论
人工智能在医疗保健领域的应用正在被讨论，专家们强调了对当前部署在临床环境中的模型的可靠性和可信度的担忧。在“Imagination in Action”活动的小组成员就人工智能融入连续护理的挑战进行了辩论，强调需要健壮、透明的系统，而不是不透明的“黑箱”。主要担忧包括数据完整性、网络安全风险以及更新遗留电子健康记录系统以适应新的人工智能工具的难度。
-
Genesis AI partners with Incyte in $120M drug discovery deal
Genesis Molecular AI has secured a significant partnership with Incyte, a global biotech company, valued at $120 million. This deal includes $80 million in upfront cash and a $40 million equity investment, with potentia…
-
FDA approves first gene therapy for genetic deafness
The FDA has approved the first gene therapy designed to treat deafness caused by a specific genetic mutation. This groundbreaking treatment targets the OTOF gene, which is crucial for transmitting sound signals from the…
-
Eli Lilly invests $2.75B in AI-designed drugs from Insilico Medicine
Eli Lilly has acquired drug candidates designed by Insilico Medicine for $2.75 billion, highlighting AI's growing role in pharmaceutical discovery. This significant investment underscores a broader trend, with the pharm…
-
Pharma giants Eli Lilly and Nvidia partner to accelerate AI drug discovery
Eli Lilly and Company has partnered with Nvidia to develop a powerful supercomputer aimed at accelerating drug discovery using artificial intelligence. This collaboration, announced in October and expanded in January wi…
-
Eli Lilly raises full-year revenue forecast after Q1 sales jump 56%
DeepSeek has released a significant update to its AI models, marking a notable advancement for the company. This update comes as Eli Lilly reported a 56% year-over-year revenue increase for its first quarter, leading th…
-
DeepSeek announces major update, Eli Lilly raises full-year guidance
DeepSeek has announced a significant update, marking a new phase for the company. The update is accompanied by news that Elon Musk stated he co-founded OpenAI with the intention of saving humanity. Additionally, Samsung…
-
Eli Lilly bets $2.75B on AI drug discovery firm Insilico Medicine
Eli Lilly has invested $2.75 billion in Insilico Medicine, a Hong Kong-based company, for AI-designed drugs. This significant deal highlights the growing trend of major pharmaceutical companies leveraging artificial int…
-
Google DeepMind衍生公司Isomorphic Labs为AI药物试验筹集21亿美元
Isomorphic Labs是一家由Google DeepMind孵化的人工智能驱动的药物发现公司，已在B轮融资中获得超过20亿美元。这笔巨额投资由Thrive Capital领投，将用于扩展其专有的药物设计引擎IsoDDE，并将其候选药物管线推进到人体临床试验阶段。该公司利用DeepMind的AlphaFold技术来预测蛋白质结构并设计高效、低副作用的药物。
-
AI falls short in cancer fight, experts say; deeper AI needed
AI has not yet delivered on its promise to significantly impact cancer treatment, despite hopes that advanced algorithms could revolutionize drug discovery and development. Critics argue that the challenges in medicine …